Investment
Features
FeesSafety
Academy
More
Pluang+

JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

Market News
19 Oct 2026
Not Specified
View Source
Bullish
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakistan's informal workforce, serving 2.38 million active customers and issuing 27.7 million policies. The award highlights JazzCash's role in expanding financial access and embedding insurance into everyday transactions. JazzCash was also a finalist for its government welfare disbursement partnership, reinforcing its impact on Pakistan's digital financial ecosystem.

JazzCash's health-protection platform Sehat+ serves 2.38 million active customers and issued 27.7 million policies, highlighting its scale in InsurTech innovation. For readers following Financials-sector stocks on Pluang, here is the market snapshot as of Oct 19, 2026 17:41 WIB: out of 142 priced stocks, 67 rose and 39 fell. Notable movers include MARA at USD 7.70 (+2.26%), ICE at USD 158.20 (-2.08%), and GEMI at USD 3.64 (+1.96%).

More News

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...

Others
Neutral
22 minutes ago
EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...

Company Fundamentals
Neutral
22 minutes ago
Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Market News
Bullish
22 minutes ago
Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...

Company Fundamentals
Bullish
22 minutes ago
Haleon launches interactive wellness pop-up in Toronto to boost everyday health confidence

Haleon launches interactive wellness pop-up in Toronto to boost everyday health confidence

Haleon Canada is opening the Haleon Health House in Toronto on October 23, an immersive pop-up experience designed to educate visitors on everyday health through interactive exhibits and expert advice. The event features trusted Haleon brands like Ad...

Others
Bullish
22 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App